A HIGHLY EFFICIENT SYNTHESIS OF RWJ-47639 - A NOVEL, ORALLY-ACTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST

被引:3
|
作者
HSI, JD
MURRAY, WV
GILL, A
机构
关键词
D O I
10.1016/S0960-894X(00)80010-4
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
RWJ 47639 (1), a new, potent and orally active angiotensin II receptor antagonist was synthesized by an efficient three-step process utilizing addition of a substituted phenyllithium to an ortho-fluorophenyloxazoline as the key step.
引用
收藏
页码:1523 / 1526
页数:4
相关论文
共 50 条
  • [31] DISCOVERY OF A NOVEL CLASS OF ORALLY ACTIVE, NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS
    DE, B
    WINN, M
    ZYDOWSKY, TM
    KERKMAN, DJ
    DEBERNARDIS, JF
    LEE, J
    BUCKNER, S
    WARNER, R
    BRUNE, M
    HANCOCK, A
    OPGENORTH, T
    MARSH, K
    JOURNAL OF MEDICINAL CHEMISTRY, 1992, 35 (20) : 3714 - 3717
  • [32] Pharmacological and pharmacokinetic evaluation of EXP3312, an orally-active non-peptide angiotensin II-receptor antagonist
    Wong, YN
    Wong, PC
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 1996, 48 (05) : 492 - 497
  • [33] SULFONYLUREAS AND SULFONYLCARBAMATES AS NEW NON-TETRAZOLE ANGIOTENSIN-II RECEPTOR ANTAGONISTS - DISCOVERY OF A HIGHLY POTENT ORALLY-ACTIVE (IMIDAZOLYLBIPHENYLYL) SULFONYLUREA (HR-720)
    DEPREZ, P
    GUILLAUME, J
    BECKER, R
    CORBIER, A
    DIDIERLAURENT, S
    FORTIN, M
    FRECHET, D
    HAMON, G
    HECKMANN, B
    HEITSCH, H
    KLEEMANN, HW
    VEVERT, JP
    VINCENT, JC
    WAGNER, A
    ZHANG, JD
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2357 - 2377
  • [34] TRIAZOLINONES AS NONPEPTIDE ANGIOTENSIN-II ANTAGONISTS .2. DISCOVERY OF A POTENT AND ORALLY-ACTIVE TRIAZOLINONE ACYLSULFONAMIDE
    CHANG, LL
    ASHTON, WT
    FLANAGAN, KL
    NAYLOR, EM
    CHAKRAVARTY, PK
    PATCHETT, AA
    GREENLEE, WJ
    BENDESKY, RJ
    CHEN, TB
    FAUST, KA
    KLING, PJ
    SCHAFFER, LW
    SCHORN, TW
    ZINGARO, GJ
    CHANG, RSL
    LOTTI, VJ
    KIVLIGHN, SD
    SIEGL, PKS
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1994, 4 (01) : 115 - 120
  • [35] SYNTHESIS AND IDENTIFICATION OF A NOVEL TETRAZOLE METABOLITE OF THE ANGIOTENSIN-II RECEPTOR ANTAGONIST DUP 753
    STEARNS, RA
    DOSS, GA
    MILLER, RR
    CHIU, SHL
    DRUG METABOLISM AND DISPOSITION, 1991, 19 (06) : 1160 - 1162
  • [36] THE PHARMACOLOGY OF SCH-50911 - A NOVEL, ORALLY-ACTIVE GABA-B RECEPTOR ANTAGONIST
    BOLSER, DC
    BLYTHIN, DJ
    CHAPMAN, RW
    EGAN, RW
    HEY, JA
    RIZZO, C
    KUO, SC
    KREUTNER, W
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1995, 274 (03): : 1393 - 1398
  • [37] DESIGN AND SYNTHESIS OF L-703,014, AN ORALLY-ACTIVE, NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONIST
    IHLE, NC
    WHITMAN, DB
    DUGGAN, ME
    ANDERSON, PS
    HARTMAN, GD
    HOFFMAN, WF
    MORENO, OA
    SMITH, RL
    GOULD, RJ
    LYNCH, R
    ZHANG, GX
    HOLAHAN, MM
    LYNCH, JJ
    STRANIERI, MT
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1994, 208 : 208 - MEDI
  • [38] NONPEPTIDE FIBRINOGEN RECEPTOR ANTAGONISTS .7. DESIGN AND SYNTHESIS OF A POTENT, ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONIST
    DUGGAN, ME
    NAYLOROLSEN, AM
    PERKINS, JJ
    ANDERSON, PS
    CHANG, CTC
    COOK, JJ
    GOULD, RJ
    IHLE, NC
    HARTMAN, GD
    LYNCH, JJ
    LYNCH, RJ
    MANNO, PD
    SCHAFFER, LW
    SMITH, RL
    JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) : 3332 - 3341
  • [39] SUBSTITUTED 4-BENZYLOXYL-NAPHTHYRIDINE DERIVATIVE - A NOVEL, POTENT AND ORALLY-EFFECTIVE ANGIOTENSIN-II RECEPTOR ANTAGONIST
    OLDHAM, AA
    ALLOTT, CP
    MAJOR, JS
    SMITH, CFC
    LUKE, RWA
    ROBERTS, DA
    BRADBURY, RH
    PEARCE, RJ
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P139 - P139
  • [40] POTENT, ORALLY ACTIVE, 1,5-NAPHTHYRIDINE ANGIOTENSIN-II RECEPTOR ANTAGONISTS
    BRADBURY, RH
    EDWARDS, MP
    LUKE, RWA
    MAJOR, JS
    OLDHAM, AA
    PEARCE, RJ
    ROBERTS, DA
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1991, 202 : 102 - MEDI